Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells.

Gao L, Gorski JL, Chen CS.

Am J Pathol. 2011 Mar;178(3):969-74. doi: 10.1016/j.ajpath.2010.11.051.

2.

MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice.

Zou W, Greenblatt MB, Shim JH, Kant S, Zhai B, Lotinun S, Brady N, Hu DZ, Gygi SP, Baron R, Davis RJ, Jones D, Glimcher LH.

J Clin Invest. 2011 Nov;121(11):4383-92. doi: 10.1172/JCI59041. Epub 2011 Oct 3.

3.
4.

Faciogenital dysplasia protein (FGD1) regulates export of cargo proteins from the golgi complex via Cdc42 activation.

Egorov MV, Capestrano M, Vorontsova OA, Di Pentima A, Egorova AV, Mariggiò S, Ayala MI, Tetè S, Gorski JL, Luini A, Buccione R, Polishchuk RS.

Mol Biol Cell. 2009 May;20(9):2413-27. doi: 10.1091/mbc.E08-11-1136. Epub 2009 Mar 4.

6.

FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia.

Genot E, Daubon T, Sorrentino V, Buccione R.

J Cell Sci. 2012 Jul 15;125(Pt 14):3265-70. doi: 10.1242/jcs.093419. Epub 2012 Aug 1.

7.

Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.

Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggiò S, Tetè S, Polishchuk R, Castronovo V, Buccione R.

Cancer Res. 2009 Feb 1;69(3):747-52. doi: 10.1158/0008-5472.CAN-08-1980. Epub 2009 Jan 13.

8.

Genomic organization of the faciogenital dysplasia (FGD1; Aarskog syndrome) gene.

Pasteris NG, Buckler J, Cadle AB, Gorski JL.

Genomics. 1997 Aug 1;43(3):390-4.

PMID:
9268645
9.
10.
13.

The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs-specific guanine-nucleotide exchange factor.

Zheng Y, Fischer DJ, Santos MF, Tigyi G, Pasteris NG, Gorski JL, Xu Y.

J Biol Chem. 1996 Dec 27;271(52):33169-72.

14.

Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape.

Hou P, Estrada L, Kinley AW, Parsons JT, Vojtek AB, Gorski JL.

Hum Mol Genet. 2003 Aug 15;12(16):1981-93.

PMID:
12913069
15.

CDC42 and FGD1 cause distinct signaling and transforming activities.

Whitehead IP, Abe K, Gorski JL, Der CJ.

Mol Cell Biol. 1998 Aug;18(8):4689-97.

16.

Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1.

Hayakawa M, Matsushima M, Hagiwara H, Oshima T, Fujino T, Ando K, Kikugawa K, Tanaka H, Miyazawa K, Kitagawa M.

Genes Cells. 2008 Apr;13(4):329-42. doi: 10.1111/j.1365-2443.2008.01168.x.

18.

Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease.

Pedigo NG, Van Delden D, Walters L, Farrell CL.

Physiol Genomics. 2016 Jul 1;48(7):446-54. doi: 10.1152/physiolgenomics.00101.2015. Epub 2016 May 6. Review.

PMID:
27199457
19.

Supplemental Content

Support Center